These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34933425)

  • 1. [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].
    Xia QY; Lu D; Zhang JM; Wei YC; Yang MM; Yang ZY; Cao MB
    Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1069-1076. PubMed ID: 34933425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills in regulating intestinal flora and improving non-alcoholic steatohepatitis].
    Jian CF; Zhang BY; Wang CP; Sha YR; Li AR; Gong PY; Gu J; Tan R
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2038-2048. PubMed ID: 35531719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Modified Xiaoyao Powder on intestinal barrier and intestinal flora in mice with metabolic associated fatty liver disease based on "gut-liver axis"].
    Jia CC; Yue R; Xiang WW; He YD; Liu X; Wang FJ
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4499-4509. PubMed ID: 39307786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease.
    Yan S; Zhang S; Du A; Miao H; Lu B; Huang Z; Ji L
    Phytomedicine; 2021 Oct; 91():153666. PubMed ID: 34339944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model.
    Zhang W; Cheng W; Li J; Huang Z; Lin H; Zhang W
    mSystems; 2024 Mar; 9(3):e0102723. PubMed ID: 38421203
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
    Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
    Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
    Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of
    Gong MJ; Zhu CY; Zou ZJ; Han B; Huang P
    J Pharm Biomed Anal; 2021 Apr; 197():113964. PubMed ID: 33601157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet.
    Bi CR; Sun JT; Du J; Chu LY; Li YJ; Jia XY; Liu Y; Zhang WP; Li YC; Liu YJ
    Front Cell Infect Microbiol; 2022; 12():1005318. PubMed ID: 36683694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of PGAM5 knockout on high fat high fructose diet and methionine choline-deficient diet induced non-alcoholic steatohepatitis (NASH) in mice.
    Li L; Guo C; Yu Y; Tie L; Lu G; Liu F; Han X; Ji L; Zou X
    Cell Biosci; 2023 Aug; 13(1):154. PubMed ID: 37605246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis.
    Yang Z; Xia Q; Lu D; Yue H; Zhang J; Li Y; Zhang B; Li X; Cao M
    Aging (Albany NY); 2020 Nov; 12(21):21660-21673. PubMed ID: 33168782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parathyroid hormone-related protein aggravates nonalcoholic fatty liver disease induced by methionine choline-deficient diet in mice].
    Qin B; Diao N; Bai L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1037-1043. PubMed ID: 34308853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
    Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
    Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
    Galastri S; Zamara E; Milani S; Novo E; Provenzano A; Delogu W; Vizzutti F; Sutti S; Locatelli I; Navari N; Vivoli E; Caligiuri A; Pinzani M; Albano E; Parola M; Marra F
    Clin Sci (Lond); 2012 Oct; 123(7):459-71. PubMed ID: 22545719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emodin worsens methionine-choline-deficient diet-induced non-alcoholic fatty liver disease in mice].
    Liu Q; Yu F; Yu N; Shi M; Wang F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):620-4. PubMed ID: 25940288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.
    Cui Y; Guo C; Xia Z; Xue Y; Song B; Hu W; He X; Liang S; Wei Y; Zhang C; Wang H; Xu D; Zhang S; Fang J
    Acta Biomater; 2023 Oct; 169():500-516. PubMed ID: 37574157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.